key: cord-0888183-l5f03690
authors: Renteria, Axel E.; Mfuna Endam, Leandra; Adam, Damien; Filali-Mouhim, Ali; Maniakas, Anastasios; Rousseau, Simon; Brochiero, Emmanuelle; Gallo, Stefania; Desrosiers, Martin
title: Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2
date: 2020-11-03
journal: Am J Respir Cell Mol Biol
DOI: 10.1165/rcmb.2020-0285le
sha: b59886a1692c1aae2b45ad3f1b28524756b281ab
doc_id: 888183
cord_uid: l5f03690

BACKGROUND TMPRSS2, ACE2 and TMPRSS11D are genes coding for proteins necessary for SARS-CoV-2 activation, infection and transmission. Once SARS-CoV-2 enters the host cell, it leads to an exaggerated inflammatory state of the lungs mediated by overexpressed TNF-, IL-6, and IL-1β. We assessed azithromycin's effect on the aforementioned genes and their associated pathways to evaluate its potential use as a possible treatment. OBJECTIVE Confirm the role azithromycin may play in the regulation of pathways and genes involved in inflammation and SARS-CoV-2 activation and cell-to-cell transmission. METHODS Primary airway nasal epithelial cells collected from nasal biopsies of three patients with chronic rhinosinusitis (CRS) were primary cultured and treated or not with 10µg of azithromycin. RNA was extracted from these samples and analyzed using a microarray chip. Differential gene expression profiles and gene set enrichment analysis (GSEA) were obtained between both groups. RESULTS Cell cultures treated with 10µg of azithromycin significantly downregulated receptor-mediated endocytosis canonical pathways involving TMPRSS2 and TMPRSS11D genes. Downregulated inflammation-associated genes included IL-1β and NDST1. Interestingly, numerous genes in the cholesterol biosynthesis pathway were significantly upregulated as part of a potential process named drug-induced phospholipidosis (DLP). CONCLUSIONS This proof of concept demonstrates azithromycin downregulates pathways involving serine proteases TMPRSS2 and TMPRSS11D required for SARS-CoV-2 activation and its cell-to-cell transmission while downregulating pro-inflammatory cytokine IL-1β, NDST-1 and their associated pathways. This may help reduce the characteristic excessive respiratory epithelial inflammation, key feature of SARS-CoV-2 infection. Finally, azithromycin may also decrease available cholesterol in lipid rafts which may hinder SARS-CoV-2 infection.

Briefly, three previously enrolled patients who were part of a larger descriptive study were asked to participate in this pilot study. These patients had a diagnosis of chronic rhinosinusitis according to the published American Association of Otorhinolaryngology -Head and Neck Surgery guidelines and were scheduled for endoscopic sinus surgery. A nasal biopsy at the level of the anterior ethmoid bulla was taken at the time of surgery. Three male patients of age 41, 49, and 53 years with no significant comorbidities other than chronic obstructive pulmonary disease in the latter were the sources of the nasal biopsies. No patient had received oral corticosteroids or topical or systemic antibiotic therapy in the preceding 30 days. All subjects had ceased topical intranasal corticosteroids 14 days before surgery.

Primary airway nasal epithelial cells were isolated from biopsies of the anterior ethmoid bulla and cultured according to a modified protocol from Maillé and colleagues (8) . Through immunohistochemistry, the freshly isolated cell suspension was characterized to be composed of basal (cytokeratine 13-positive cells), ciliated (bIV-tubulin-positive cells), and goblet (MUC5ACpositive cells) nasal epithelial cells ( Figure E1 in the data supplement). These cell types have all been described as expressing ACE2 and harbor the potential of sustaining a SARS-CoV-2 infection (9) . To obtain a uniform and consistent cell population during our experiments with azithromycin treatment, this cell suspension was then expanded for 5-7 days, leading to a homogenous cell culture, predominantly composed from progenitor basal cells.

Based on previous azithromycin toxicity studies on human bronchial airway epithelial cells, the plate was treated with 10 mg/ml of azithromycin diluted in DMSO (Sigma-Aldrich) or a mock.

RNA was extracted from these cultures treated with azithromycin or mock. Then, samples for microarray studies were prepared using the Illumina RNA Amplification TotalPrep kit from Ambion (Life Technologies) and collected with the Illumina Bead Array Reader (IIlumina). Raw gene expression data was preprocessed, and pathway analysis was performed using the gene set enrichment analysis. Differential Gene Expression was then performed using the LIMMA package from Bioconductor (10) . For a more detailed Methods section, refer to the data supplement.

Pathway analysis using gene set enrichment analysis showed that cultures treated with 10 mg of azithromycin demonstrated a significant downregulation in serine hydrolase activity pathway (normalized enrichment score [NES] = 21.8720, P = 0.0020) together with endocytosis (NES = 21.6866, P = 0.0020) and receptor-mediated endocytosis pathway (NES = 21.5139, P = 0.0124). This is particularly interesting because the strongest associated genes included TMPRSS2 and TMPRSS11D.

Azithromycin's antiinflammatory properties were also demonstrated by a significant downregulation of Hallmark and Gene Ontology canonical inflammatory response pathways (NES = 22.0729, P = 0.0005 and NES = 22.0569, P = 0.0020, respectively) together with IFN-g and IFN-a pathways (NES = 22.1717, P = 0.0005 and NES = 22.1484, P = 0.0005, respectively). Moreover, downregulation of key IL signaling pathways, including IL-2, IL-6, and IL-8, was also seen.

Interestingly, Gene Ontology's sterol biosynthetic process and Hallmark's cholesterol homeostasis were upregulated (NES = 3.0991, P = 0.0020 and NES = 3.0543, P = 0.0005, respectively). Selected significant pathways are presented in Figure 1A and summarized in Table E1 . A full table of all significantly modulated canonical pathways are presented in Table E3 .

Differential Gene Expression of cultures treated with 10 mg of azithromycin demonstrated a significant downregulation of IL-1b (fold change = 21.411, P = 0.0094) and NDST-1 (fold change = 21.345, P = 0.0276).

Interestingly, within the lipid and cholesterol biosynthesis pathways, most of its individual genes were significantly upregulated. A display of selected genes is found in Figure 1B and Table E2. A full table of all tested genes are presented in  Table E4 . This letter has a data supplement, which is accessible from this issue's table of contents at www.atsjournals.org.

Originally Published in Press as DOI: 10.1165/rcmb.2020-0285LE on August 28, 2020

With this study, we provide some evidence that azithromycin downregulates key pathways involving genes TMPRSS2 and TMPRSS11D, which code for two serine proteases required by SARS-CoV-2 for its activation (2) and cell-to-cell transmission (11) , respectively.

Furthermore, downregulating IL-1b and NDST-1 (12) together with associated inflammation and leukocyte recruitment pathways may help reduce the characteristic excessive respiratory epithelial inflammation, a key feature of SARS-CoV-2 infection.

Finally, the unexpected upregulation of multiple genes involved in cholesterol biosynthesis is believed to be a process known as drug-induced phospholipidosis, which may decrease cholesterol in cell membrane lipid rafts (5) . This may hinder SARS-CoV-2 infection, as in vitro studies demonstrated that depletion of cholesterol in the cell membrane resulted in decreased SARS-CoV-1 cell infection (13, 14) . Moreover, our data are in line with a previous in vitro study in which azithromycin upregulated lipid and cholesterol pathways while decreasing important proinflammatory cytokines in differentiated human bronchial epithelial cell cultures (15) . Our study should, however, be interpreted with caution because it is limited by its small sample size, the inclusion of only a male population, and the lack of experiments validating that the observed changes in gene expression had an impact on protein levels. Nevertheless, our findings harbor significant information to better orient larger in vivo or clinical studies on future treatments against SARS-CoV-2 infections. n Author disclosures are available with the text of this letter at www.atsjournals.org. 

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Azithromycin: mechanisms of action and their relevance for clinical applications

Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-kB signaling pathways

Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells

Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-a after injury

HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Orchestrating high-throughput genomic analysis with bioconductor

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease

Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation

Natural small molecules as inhibitors of coronavirus lipiddependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?

SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway

Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia